肺炎合併に伴う認知症患者の予後についての検討 by 間辺 利江 & Manabe Toshie
Prognosis of patients with dementia
complicated with pneumonia
著者 間辺 利江
内容記述 この博士論文は内容の要約のみの公開（または一部
非公開）になっています  
year 2016
その他のタイトル 肺炎合併に伴う認知症患者の予後についての検討
学位授与大学  筑波大学 (University of Tsukuba) 
学位授与年度 2016
報告番号 12102甲第7923号
URL http://hdl.handle.net/2241/00146866
 〔博士論文概要〕 
 
 
Prognosis of patients with dementia complicated with pneumonia 
（肺炎合併に伴う認知症患者の予後についての検討） 
 
 
平成 28年度 
 
 
 
 
 
 
 
 
 
間辺 利江 
筑波大学人間総合科学研究科 
ヒューマン・ケア科学専攻 
  
 Prognosis of patients with dementia complicated with pneumonia 
 
Toshie Manabe 
 
Purposes: 
Dementia is increasingly becoming a major healthcare challenge as the 
population ages. Dementia occurs when the brain is affected by certain diseases or 
conditions. Currently, many different types of dementia were determined. Among them, 
Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), and Vascular dementia 
(VaD) encompass approximately 90% of the total population of dementia in Japan. 
Persons with dementia tend to die at an earlier age compared persons without dementia. 
Several studies reported that pneumonia increased the risk of death on dementia. 
However, the disease prognosis of dementia with pneumonia has not been fully 
understood as well as the risk factors relating to the survival-time on dementia 
complicated with pneumonia.  
The aim of the present study was to elucidate the effects of pneumonia for the 
disease prognosis and prognostic factors on neuropathologically confirmed patients with 
AD, DLB, and VaD.  
The purposes on each sub-study were: (Study 1) to determine the cause of 
death; (Study 2) to evaluate the time from dementia onset to death (survival-time) and 
to assess the influence of pneumonia complication and prognostic factors on patients 
with AD, DLB, and VaD; (Study 3) to examine the survival-time and prognostic factors 
on patients with DLB. 
Subjects and Methods: 
The retrospective observational studies were conducted. The subjects of study 
were hospitalized and deceased patients between January 2005 and December 2014 in 
Fukushimura Hospital, Toyohashi, Japan. All patients were underwent brain autopsies in 
the study site. Data relating to the general and clinical backgrounds of the patients, 
clinical time courses, and clinical conditions on patients during the hospitalization 
including swallowing dysfunction, nosocomial infections, percutaneous endoscopic 
gastrostomy (PEG), medications, and results of neuropathological examinations were 
collected. The cause of death (Study 1), the survival-time and the risk factors for the 
survival-time (Study 2) were analyzed for all 157 eligible patients, and compared 
among patients with AD, DLB, and VaD, and between patients with and without 
pneumonia. The risk factors on the survival-time on DLB complicated with pneumonia 
were examined on 42 patients with DLB (Study 3).  
In the statistical analysis, the Mann-Whitney U test and the Kruskal–Wallis 
tests were used for continuous variables, and the Chi-squared and Fisher’s exact tests 
were used for categorical variables. Survival curves of the number of years on 
survival-times of dementia in groups of AD, DLB, and VaD with or without pneumonia 
were analyzed by the Kaplan–Meier method and comparisons were made using the 
log-rank test. To evaluate independent factors for the survival time of dementia, a 
step-wise method was used for a Cox proportional hazard analysis.  
The study was approved by the Institutional Review Boards of the University 
of Tsukuba and Fukushimura Hospital. Written informed consent was obtained from 
patients’ relatives.  
Results: 
Among 230 cases who underwent autopsy during the observational period in 
the study site, 157 patients with AD (63), DLB (42), and VaD (52) were eligible to the 
study.  
Study 1 
The patients with all three major subtype of dementia complicated with pneumonia 
with high incidence. Especially, over 90% of patients with DLB had pneumonia 
complication during the hospitalization. 
Cerebral infarction and hypertension were more common comorbidity in VaD than 
those in AD and DLB. In the patient with DLB, the main underlying cause of death 
was heart failure, but the main immediate cause of death was pneumonia. 
Study 2 
Patients with all three major subtype of dementia complicated with pneumonia with 
high incidence. The medians of total survival-time of dementia onset were 8 years 
in AD and DLB, and 5 years in VaD. The factors associating with shorter time of 
survival time of dementia were gender-male, pneumonia complication, diabetes 
mellitus, older age at onset (≥75 yr.), and VaD. 
Study 3 
The prognostic factors identified in autopsy-confirmed DLB patients with 
pneumonia were pathologically-confirmed cerebral infarction, muscle weakness of 
the lower extremities, gender-male, and older age at onset (≥ 78 years).  
Discussion: 
The present study intended to elucidate the disease prognosis and prognostic 
factors on neuropathologically confirmed patients with three major subtypes (AD, DLB, 
and VaD) of dementia in the relation of the pneumonia complication. The study revealed 
that the survival-time of patients with AD and DLB was 8 years and those with VaD was 
5 years. The survival-time of patients with DLB but without pneumonia complication 
was 5 years longer than those with pneumonia. The prognostic factors on survival-time 
of three major subtypes of dementia were gender-male, pneumonia complication, 
diabetes mellitus, older age at onset (≥75 yr.), and VaD. The prognostic factors 
identified in DLB complicated with pneumonia were pathologically-confirmed cerebral 
infarction, muscle weakness of the lower extremities, a male sex, and older age at onset 
(≥ 78 years). 
The reported survival-time on patients with dementia was various, 8 - 12 years 
in AD and 1.8 - 9.5 years in DLB. These wide range may be caused by the heterogeneity 
among these studies including the cause of death (underlying or immediate), the 
methods of diagnosis (neuropathological or clinical) and the subtypes and severity of 
dementia. Therefore, in the present study, the patients of dementia who were 
neuropathologically diagnosed on dementia were examined. In the survival-time of 
patients with AD and DLB were 8 years and 5 years in patients with VaD. This 
difference among types of dementia may cause the different pathogenesis of each types 
of dementia. VaD is a progressive disease and may associate with some types of 
cerebral events. In addition, VaD has systemic vascular damages, and it is reasonable to 
suppose that these damages, in part, contributing shortening the survival-time. As the 
result, cerebral infarction was a more common comorbidity in VaD than those in AD 
and DLB. AD and DLB are neurodegenerative diseases, and they may have slower 
progression than those of VaD. In this study of DLB, cerebral infarction was one of the 
independent factors that associated the shortness of survival-time (Study 3). The result 
indicated the possibility of the long-term influence of cerebral infarction, including 
asymptomatic cerebral infarction and a history of small cerebral infarctions, on the 
progression of DLB. 
The pneumonia complication was determined as the prognostic factor on 
patients with AD, DLB and VaD. Although the survival-time both on AD and DLB was 
same as  8 years, only survival-time of patients with DLB with- and 
without-pneumonia was significant. Although the number of DLB patients without 
pneumonia was small, the more effects of pneumonia were possibly existed in DLB 
than those in AD. Pneumonia results in further aggravation of cardiac and circulatory 
dysfunction in DLB. Once patients with DLB reach the terminal stage, pneumonia can 
lead to mortality, due to the decreasing ventilator response to hypercapnia. 
 In the study on DLB, muscle weakness of the lower extremities tended to 
effect to shorter survival-time on patients with DLB (Study 3). The previous studies 
indicated an association between muscle strength of the extremities and the risk of death 
in older adults. Similar to these observations, the results of the present study suggest 
that weakness of the extremities in DLB patients may be associated with a low 
respiratory function and thus aggravate the poor prognosis for patients with pneumonia. 
These may suggested that the deterioration of lung function would risk being dementia 
and the risk to shortness of life expectancy once dementia is occurred. 
Conclusions: 
 The careful management on pneumonia are crucial for maximizing the patients’ 
life expectancy, especially for patients who developed dementia in older age. Cerebral 
infarction and diabetes mellitus are also import for clinical management on older adults 
with dementia. The study warrants further prospective cohort studies with alternative 
and larger populations for generalizing the results of present study. 
 
 
